The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Mechanism and its regulation of tumor-induced angiogenesis
Open accessAbstract
Tumor angiogenesis is the proliferation of a network of blood vessels that penetrates into cancerous growths, supplying nutrients and oxygen and removing waste products. The process of angiogenesis plays an important role in many physiological and pathological conditions. Solid tumors depend on angiogenesis for growth and metastasis in a hostile environment. In the prevascular phase, the tumor is rarely larger than 2 to 3 mm(3) and may contain a million or more cells. Up to this size, tumor cells can obtain the necessary oxygen and nutrient supplies required for growth and survival by simple passive diffusion. The properties of tumors to release and induce several angiogenic and anti-angiogenic factors which play crucial roles in regulating endothelial cell (EC) proliferation, migration, apoptosis or survival, cell-cell and cell-matrix adhesion through different intracellular signaling are thought to be the essential mechanisms during tumor-induced angiogenesis. Tumor angiogenesis actually starts with tumor cells releasing molecules that send signals to surrounding normal host tissue. This signaling activates certain genes in the host tissue that, in turn, make proteins to encourage growth of new blood vessels. In this review, we focus the mechanisms of tumor-induced angiogenesis, with an emphasis on the regulatory role of several angiogenic and anti-angiogenic agents during the angiogenic process in tumors. Advances in understanding the mechanisms of tumor angiogenesis have led to the development of several most effective anti-angiogenic and anti-metastatic therapeutic agents and also have provided several techniques for the regulation of cancer's angiogenic switch. The suggestion is made that standard cytotoxic chemotherapy and angiogenesis inhibitors used in combination may produce complementary therapeutic benefits in the treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Pardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.109006 · Cited by 152
RetractedPardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109006200 · Cited by 152
RetractedSherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Gerber, H.-P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30336 · Cited by 1,981
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez, D. E., Alonso, D. F., Yoshiji, H., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 1,508
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Ausprunk, D. H., & Folkman, J. (1977) · Microvascular Research · doi:10.1016/0026-2862(77)90141-8 · Cited by 1,281
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
Ferrara, N. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1358 · Cited by 1,085
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/71517 · Cited by 1,020
Gerber, H.-P., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13313 · Cited by 981
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
Lyons, R. M., Keski-Oja, J., & Moses, H. L. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.5.1659 · Cited by 963
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Relf, M., LeJeune, S., Scott, P. A. E., Fox, S. B., Smith, K. A., Leek, R., Moghaddam, A., Whitehouse, R. M., Bicknell, R., & Harris, A. L. (1997) · PubMed · Cited by 833
The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors
LAMBERTS, S. W. J., KRENNING, E. P., & REUBI, J.-C. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-450 · Cited by 805
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
Lyons, R. M., Gentry, L. E., Purchio, A. F., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1361 · Cited by 737
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
Esser, S., Lampugnani, M. G., Corada, M., Dejana, E., & Risau, W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.13.1853 · Cited by 715
Lobov, I. B., Brooks, P. C., & Lang, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172161899 · Cited by 676
Kim, I., Kim, H. G., So, J.-N., Kim, J. H., Kwak, H. J., & Koh, G. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.1.24 · Cited by 649
Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway
Papapetropoulos, A., Fulton, D., Mahboubi, K., Kalb, R. G., O'Connor, D. S., Li, F., Altieri, D. C., & Sessa, W. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9102 · Cited by 641
Sato, Y., & Rifkin, D. B. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.3.1199 · Cited by 637
Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.58 · Cited by 635
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Pepper, M. S., Ferrara, N., Orci, L., & Montesano, R. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91276-i · Cited by 615
Endostatin Induces Endothelial Cell Apoptosis
Dhanabal, M., Ramchandran, R., Waterman, M. J. F., Lu, H., Knebelmann, B., Segal, M., & Sukhatme, V. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11721 · Cited by 584
Fujio, Y., & Walsh, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16349 · Cited by 553
Senger, D. R., Ledbetter, S. R., Claffey, K. P., Papadopoulos-Sergiou, A., Peruzzi, C. A., & Detmar, M. J. (1996) · Europe PMC (PubMed Central) · Cited by 544
Jiang, B.-H., Zheng, J. Z., Aoki, M., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040560897 · Cited by 528
Unemori, E. N., Ferrara, N., Bauer, E. A., & Amento, E. P. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530317 · Cited by 526
Angiostatin binds ATP synthase on the surface of human endothelial cells
Moser, T. L., Stack, M. S., Asplin, I., Enghild, J. J., Højrup, P., Everitt, L., Hubchak, S., Schnaper, H. W., & Pizzo, S. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2811 · Cited by 526
Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., & Detmar, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13612 · Cited by 522
Jonasch, E., & Haluska, F. G. (2001) · The Oncologist · doi:10.1634/theoncologist.6-1-34 · Cited by 518
Gilmore, A. P., & Romer, L. H. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.8.1209 · Cited by 513
Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.
Kieser, A., Weich, H. A., Brandner, G., Marmé, D., & Kölch, W. (1994) · PubMed · Cited by 511
Mazure, N. M., Chen, E. Y., Laderoute, K. R., & Giaccia, A. J. (1997) · Blood · doi:10.1182/blood.v90.9.3322 · Cited by 503
Molecular mechanisms of blood vessel formation
Bussolino, F., Mantovani, A., & Persico, G. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01074-8 · Cited by 470
Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Interaction of endostatin with integrins implicated in angiogenesis
Rehn, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031564998 · Cited by 460
Pepper, M. S., Belin, D., Montesano, R., Orci, L., & Vassalli, J. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.743 · Cited by 453
Sato, Y., Tsuboi, R., Lyons, R., Moses, H., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.757 · Cited by 444
Kim, Y.-M., Hwang, S., Kim, Y.-M., Pyun, B.-J., Kim, T.-Y., Lee, S.-T., Gho, Y. S., & Kwon, Y.-G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202771200 · Cited by 432
Morales-Ruiz, M., Fulton, D., Sowa, G., Languino, L. R., Fujio, Y., Walsh, K., & Sessa, W. C. (2000) · Circulation Research · doi:10.1161/01.res.86.8.892 · Cited by 419
Molecular pharmacology of somatostatin receptor subtypes
Patel, Y. C. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03350317 · Cited by 409
Stavri, G. T., Zachary, I. C., Baskerville, P. A., Martin, J. F., & Erusalimsky, J. D. (1995) · Circulation · doi:10.1161/01.cir.92.1.11 · Cited by 395
Gupta, K., Kshirsagar, S., Li, W., Gui, L., Ramakrishnan, S., Gupta, P., Law, P. Y., & Hebbel, R. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4359 · Cited by 379
Kringle Domains of Human Angiostatin
Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Söhndel, S., McCance, S. G., O'Reilly, M. S., Llinás, M., & Folkman, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29461 · Cited by 368
Dimmeler, S., Dernbach, E., & Zeiher, A. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01657-4 · Cited by 364
Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., NAKAYAMA, J., Nishioka, Y., Sone, S., & Kuwano, M. (2000) · PubMed · Cited by 363
Lawrence, D. A., Pircher, R., & Jullien, P. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91239-2 · Cited by 362
Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A., & Vlodavsky, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7069 · Cited by 351
Murphy, A. N., Unsworth, E. J., & Stetler‐Stevenson, W. G. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570219 · Cited by 351
Kim, Y. M., Jang, J.-W., Lee, O., Yeon, J.-H., Choi, E.-Y., Kim, K., Lee, S., & Kwon, Y. (2000) · PubMed · Cited by 347
Slaton, J. W., Perrotte, P., Inoue, K., Dinney, C. P., & Fidler, I. J. (1999) · PubMed · Cited by 337
Suzuki, M., Raab, G., Moses, M. A., Fernandez, C. A., & Klagsbrun, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31730 · Cited by 330
Kevil, C. G., Payne, D. K., Mire, E., & Alexander, J. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15099 · Cited by 320
Moser, T. L., Kenan, D. J., Ashley, T. A., Roy, J. A., Goodman, M. D., Misra, U. K., Cheek, D. J., & Pizzo, S. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131067798 · Cited by 314
Witte, L., Hicklin, D. J., Zhu, Z., Pytowski, B., Kotanides, H., Rockwell, P., & Böhlen, P. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006094117427 · Cited by 307
Akt is more than just a Bad kinase
Khwaja, A. (1999) · Nature · doi:10.1038/43354 · Cited by 299
Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., & Albini, A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<246::aid-ijc13>3.0.co;2-b · Cited by 273
Dixelius, J., Larsson, H., Sasaki, T., Holmqvist, K., Lu, L., Engström, A., Timpl, R., Welsh, M., & Claesson-Welsh, L. (2000) · Blood · doi:10.1182/blood.v95.11.3403 · Cited by 271
Sharma, K. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1688 · Cited by 269
Mandriota, S. J., Seghezzi, G., Vassalli, J.-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P., & Pepper, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9709 · Cited by 267
Akt Takes Center Stage in Angiogenesis Signaling
Dimmeler, S., & Zeiher, A. M. (2000) · Circulation Research · doi:10.1161/01.res.86.1.4 · Cited by 260
Jayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1484 · Cited by 258
Wheeler-Jones, C., Abu-Ghazaleh, R., Cospedal, R., Houliston, R. A., Martin, J., & Zachary, I. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01481-6 · Cited by 255
Inhibition of Angiogenesis by Interleukin 4
Volpert, O. V., Fong, T., Koch, A. E., Peterson, J. D., Waltenbaugh, C., Tepper, R. I., & Bouck, N. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1039 · Cited by 255
Kim, I., Kim, H. G., Moon, S.-O., Chae, S. W., So, J.-N., Koh, K. N., Ahn, B. C., & Koh, G. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.9.952 · Cited by 255
Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma
Bar-Eli, M. (1999) · Pathobiology · doi:10.1159/000028045 · Cited by 247
Mazure, N. M., Chen, E. Y., Yeh, P., Laderoute, K. R., & Giaccia, A. J. (1996) · PubMed · Cited by 239
Griscelli, F., Li, H., Bennaceur-Griscelli, A., Soria, J., Opolon, P., Soria, C., Perricaudet, M., Yeh, P., & Lu, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6367 · Cited by 239
Oncogenes as inducers of tumor angiogenesis
Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marm�, D., & Kerbel, R. S. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690598 · Cited by 235
Multiple forms of angiostatin induce apoptosis in endothelial cells.
Lucas, R., Holmgren, L., Garcia, I., Jiménez, B., Mandriota, S. J., Borlat, F., Sim, B. K. L., Wu, Z., Grau, G. E., Shing, Y., et al. (1998) · PubMed · doi:10.1182/blood.v92.12.4730 · Cited by 227
Crystal structure of the angiogenesis inhibitor endostatin at 1.5Aresolution
Hohenester, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1656 · Cited by 211
Büchler, P., Reber, H. A., Büchler, M., Shrinkante, S., Büchler, M. W., Friess, H., Semenza, G. L., & Hines, O. J. (2003) · Pancreas · doi:10.1097/00006676-200301000-00010 · Cited by 206
Lal, B. K., Varma, S., Pappas, P. J., Hobson, R. W., & Durán, W. N. (2001) · Microvascular Research · doi:10.1006/mvre.2001.2338 · Cited by 197
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
Berra, E., Milanini, J., Richard, D. E., Le Gall, M., Viñals, F., Gothié, E., Roux, D., Pagès, G., & Pouysségur, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00423-8 · Cited by 196
Kohn, S., Nagy, J. A., Dvorak, H. F., & Dvořàk, A. M. (1992) · PubMed · Cited by 190
Smith, M. R., Kung, H.-F., Durum, S. K., Colburn, N. H., & Sun, Y. (1997) · Cytokine · doi:10.1006/cyto.1997.0233 · Cited by 188
Gelatinase A activity directly modulates melanoma cell adhesion and spreading.
Ray, J. M., & Stetler-Stevenson, W. G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07072.x · Cited by 187
Mandriota, S. J., & Pepper, M. S. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.18.2293 · Cited by 187
Volpert, O. V., Lawler, J., & Bouck, N. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6343 · Cited by 186
YUAN, A., YANG, P.-C., YU, C.-J., CHEN, W.-J., LIN, F.-Y., KUO, S.-H., & LUH, K.-T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.2002108 · Cited by 173
Hajitou, A., Grignet‐Debrus, C., Devy, L., Berndt, S., Blacher, S., Deroanne, C. F., Bajou, K., Fong, T., Chiang, Y., Foidart, J., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0109fje · Cited by 165
Mechanisms Which Mediate the Antiapoptotic Effects of Angiopoietin-1 on Endothelial Cells
Harfouche, R., Hasséssian, H., Guo, Y., Faivre, V., Srikant, C. B., Yancopoulos, G. D., & Hussain, S. N. A. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2421 · Cited by 164
Mandriota, S. J., Menoud, P.-A., & Pepper, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11500 · Cited by 160
Tang, H., Kerins, D. M., Hao, Q., Inagami, T., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18268 · Cited by 159
Regulation of Tumor Growth and Metastasis by Interleukin-10: The Melanoma Experience
Huang, S., Ullrich, S. E., & Bar-Eli, M. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313532 · Cited by 159
Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).
Chiarugi, V. P., Magnelli, L., & Gallo, O. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2.6.715 · Cited by 157
Kitadai, Y., Takahashi, Y., Haruma, K., Naka, K., Sumii, K., Yokozaki, H., Yasui, W., Mukaida, N., Ohmoto, Y., Kajiyama, G., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690742 · Cited by 157
Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., & Kaibara, N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1455::aid-cncr11>3.0.co;2-l · Cited by 155
Goßmann, A., Helbich, T. H., Kuriyama, N., Ostrowitzki, S., Roberts, T. P. L., Shames, D. M., van Bruggen, N., Wendland, M. F., Israel, M. A., & Brasch, R. C. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10072 · Cited by 151
Iyer, S., Chaplin, D. J., Rosenthal, D. S., et al. (1998) · PubMed · Cited by 147
Ellenrieder, V., Hendler, S. F., Ruhland, C., Boeck, W., Adler, G., & Gress, T. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1330 · Cited by 146
Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Hicklin, D. J., Huber, J., Nakatani, T., Tsujinoue, H., Yanase, K., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.32541 · Cited by 145
Im, S., Gomez‐Manzano, C., Fueyo-Margareto, J., Liu, T. J., Li, K., Kim, J. S., Lee, H., Steck, P. A., Kyritsis, A. P., & Yung, W. K. A. (1999) · PubMed · Cited by 142
Watanabe, Y., Lee, S. W., Detmar, M. J., Ajioka, I., & Dvorak, H. F. (1997) · Oncogene · doi:10.1038/sj.onc.1201033 · Cited by 141
Urbich, C., Reissner, A., Chavakis, E., Dernbach, E., Haendeler, J., Fleming, I., Zeiher, A. M., Kaszkin, M., & Dimmeler, S. (2002) · The FASEB Journal · doi:10.1096/fj.01-0637fje · Cited by 139
Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.
Duda, D. G., Sunamura, M., Lozonschi, L., Kodama, T., Egawa, S., Matsumoto, G., Shimamura, H., Shibuya, K., Takeda, K., & Matsuno, S. (2000) · PubMed · Cited by 127
Sharma, K. H., Patel, Y., & Srikant, C. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0220 · Cited by 123
Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
Albini, A., Florio, T., Giunciuglio, D., Masiello, L., Carlone, S., Corsaro, A., Thellung, S., Cai, T., Noonan, D. M., & Schettini, G. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.6.647 · Cited by 115
Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons
Bauvois, B., Dumont, J., Mathiot, C., & Kolb, J. P. (2002) · Leukemia · doi:10.1038/sj.leu.2402472 · Cited by 106
Zhang, W., Ran, S., Sambade, M. J., Huang, X., & Thorpe, P. E. (2002) · Angiogenesis · doi:10.1023/a:1021540120521 · Cited by 105
Spurbeck, W. W., Ng, C. Y., Strom, T. S., Vanin, E. F., & Davidoff, A. M. (2002) · Blood · doi:10.1182/blood.v100.9.3361 · Cited by 101
Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells
Mentlein, R., Eichler, O., Forstreuter, F., & Held‐Feindt, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1223 · Cited by 100
Izawa, J. I., Sweeney, P., Perrotte, P., Kedar, D. J., Dong, Z., Slaton, J. W., Karashima, T., Inoue, K., Benedict, W. F., & Dinney, C. P. (2002) · PubMed · Cited by 95
Zhang, L., Gasper, W. J., Stass, S. A., Ioffe, O. B., Davis, M. A., & Mixson, A. J. (2002) · PubMed · Cited by 90
Tai, Y., Podar, K., Gupta, D., Lin, B. K., Young, G. Q., Akiyama, M., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.4.1419 · Cited by 87
Miao, H., Ornitz, D. M., Aĭngorn, E. D., Ben‐Sasson, S. A., & Vlodavsky, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119319 · Cited by 82
Marler, J. J., Rubin, J. B., Trede, N. S., Connors, S. L., Grier, H. E., Upton, J. M., Mulliken, J. B., & Folkman, J. (2002) · PEDIATRICS · doi:10.1542/peds.109.2.e37 · Cited by 78
Fernandez, H. A., Kallenbach, K., Seghezzi, G., Grossi, E. A., Colvin, S. B., Schneider, R. J., Mignatti, P., & Galloway, A. C. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1998.5534 · Cited by 76
Ozawa, S., Shinohara, H., Kanayama, H., Bruns, C. J., Bucana, C. D., Ellis, L. M., Davis, D. W., & Fidler, I. J. (2001) · Neoplasia · doi:10.1038/sj.neo.7900128 · Cited by 71
Wajih, N., & Sane, D. C. (2003) · Blood · doi:10.1182/blood-2002-02-0582 · Cited by 69
Galy, B., Créancier, L., Prado-Lourenço, L., Prats, A., & Prats, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204630 · Cited by 61
Design of growth factor antagonists with antiangiogenic and antitumor properties
Sebti, S. M., & Hamilton, A. D. (2000) · Oncogene · doi:10.1038/sj.onc.1204121 · Cited by 58
Sasamura, H., Takahashi, A., Miyao, N., Yanase, M., Masumori, N., Kitamura, H., Itoh, N., & Tsukamoto, T. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600152 · Cited by 54
The promise of anti-angiogenic cancer therapy
Oehler, M. K., & Bicknell, R. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0991 · Cited by 49
Downmodulation of bFGF-binding protein expression following restoration of p53 function
Sherif, Z. A., Nakai, S., Pirollo, K. F., Rait, A. S., & Chang, E. H. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700361 · Cited by 45
Inhibition of experimental angiogenesis of cornea by somatostatin
Wu, P., Liu, C.-C., Chen, C.-H., Kou, H., Shen, S., Lu, C.-Y., Chou, W.-Y., Sung, M., & Yang, L.-C. (2003) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-002-0591-7 · Cited by 42
Sun, X., Kanwar, J. R., Leung, E. Y., Lehnert, K., Wang, D., & Krissansen, G. W. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700370 · Cited by 39
Marion-Audibert, A.-M., Nejjari, M., Pourreyron, C., et al. (2000) · PubMed · Cited by 37
O'Mahony, C. A., Albo, D., Tuszynski, G. P., & Berger, D. H. (1998) · Surgery · doi:10.1016/s0039-6060(98)70145-x · Cited by 28
Angiogenesis Inhibitors as Cancer Therapy
Eckhardt, S. G. (1999) · Hospital Practice · doi:10.3810/hp.1999.01.124 · Cited by 19
Stage as major long term outcome predictor in minor salivary gland carcinoma
Lutgendorf (2000) · Pure Amsterdam UMC · doi:10.1002/1097-0142(20000915)89:6 · Cited by 1
Cited by
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Biological properties of “naked” metal nanoparticles☆
BHATTACHARYA, R., & MUKHERJEE, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.013 · Cited by 917
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 460
Inorganic Nanoparticles in Cancer Therapy
Bhattacharyya, S., Kudgus, R. A., Bhattacharya, R., & Mukherjee, P. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0318-0 · Cited by 395
Triterpenoids as new promising anticancer drugs
Petronelli, A., Pannitteri, G., & Testa, U. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330fd90 · Cited by 381
Metadata
- Authors
- Gupta, M. K.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2003
- Volume
- 9
- Issue
- 6
- Pages
- 1144
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W149822561
- Cited by
- 294
- References
- 131
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.